PRISM Markets
New York, February 13, 2024 - PRISM MarketView - The electric vehicle (EV) sector showcased its resilience and growth potential on Monday, as reflected in the performance of the PRISM Emerging EV Index. With carmakers steering towards more competitive pricing, the EV eco...

13 February 2024

News
BEND, Ore., February 12, 2024 - PRISM MarketView - BranchOut Food Inc.  (NASDAQ: BOF), Shares in disruptive food technology company, BranchOut Food (Nasdaq: BOF), surged nearly 100% in morning trading on Monday after the company announced it had expanded its relationship...

12 February 2024

PRISM Biotech
New York, February 12, 2024 - PRISM MarketView - T2 Biosystems, Inc. (Nasdaq: TTOO) has received 510(k) clearance from the FDA for its expanded T2Bacteria® Panel, adding the capability to detect another bacterial species, Acinetobacter baumannii (A. baumannii), to its pa...

12 February 2024

News
New York, February 12, 2024 - PRISM MarketView -  BranchOut Food (NASDAQ: BOF) has recently announced a significant expansion of its partnership with the United States' largest retailer, marking a pivotal moment valued at an estimated $7.6 million annually. This expansio...

12 February 2024

PRISM Biotech
New York, February 12, 2024 - PRISM MarketView -  Tonix Pharmaceuticals (Nasdaq: TNXP) is offering new hope to the 6 – 12 million Americans living with fibromyalgia with a potential new frontline treatment that has a completely new mechanism of action, relative to the th...

12 February 2024

News
New York, February 09, 2024 - PRISM MarketView - Matterport, Inc.,(Nasdaq: MTTR) a leader in digital twin technology, has established a significant partnership with Visiting Media, a leader in immersive sales enablement for the hospitality sector, to enhance hotel market...

9 February 2024

PRISM Biotech
New York, February 09, 2024 - PRISM MarketView - Shares in rapid test solutions company, Intelligent Bio Solutions (Nasdaq: INBS), surged nearly 240% in intraday trading on Friday after the company reported its financial results for fiscal second quarter and six months e...

9 February 2024

PRISM Biotech
New York, February 09, 2024 - PRISM MarketView - Biodexa Pharmaceuticals (Nasdaq: BDRX) has provided survival updates from its clinical study of MTX110 in patients with recurrent glioblastoma (“rGBM”). Currently, no standard of care is established for rGBM.

9 February 2024

PRISM Biotech
AIM ImmunoTech Tackles Post-COVID Fatigue
New York, February 09, 2024 - PRISM MarketView -  AIM ImmunoTech (NYSE American: AIM) has reported positive topline results from a Phase 2 study evaluating the efficacy and safety of Ampligen® as a potential therapeutic for people with the Post-COVID condition of fatigue...

9 February 2024

PRISM Cannabis
Cronos Group’s Spinach® Brand Cannabis Takes Top Spot in Canada
New York, February 08, 2024 - PRISM MarketView - Innovative global cannabinoid company, Cronos Group’s (Nasdaq: CRON), Spinach brand has emerged as the top contender in Canada’s burgeoning cannabis market, securing the coveted position of the number one flower brand in t...

8 February 2024

51
52
53
54
55
56
57
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.